Published in @OncJournal! My review paper with Oliver Sartor on Targeted Radiopharmaceuticals in Prostate Cancer: Current Data and New Trials. https://t.co/QAiYHpmxCy @UFHealthCancer#prostatecancer
In cancer care, speed is a strategy to improve outcomes. Learn from @MihirMShah1 how our high volume of patients enable us to optimize treatment planning to help reduce the time to treatment for digestive cancers. https://t.co/zcZkx05pMN
This Memorial Day, join us in taking a moment to honor those serving and to remember those who have lost their lives defending our freedom.
We are forever grateful for your courage and sacrifice.
#MilitaryAppreciationMonth#MemorialDay
Every oncologist and cancer researcher should watch this interview with @BenSasse:
https://t.co/PeTl9Eg1g8
Daraxonrasib, a “super poison for cancer,” shrank his metastatic pancreatic tumors by 76%, even though he says his skin feels and looks “nuclear.” When I learned of his diagnosis, I wanted him to get this drug (oral RAS ON inhibitor), which is poised to become first-line therapy in pancreatic cancer. I hope his experience on a clinical trial encourages more patients to enroll in studies, and pushes clinicians and researchers to keep advancing new therapies.
🚨 The incidence of breast and colorectal cancer is rising among patients 50 years and younger
Our latest feature "The Rise of Early-Onset Cancers: Investigating Breast and CRC Occurrences" discusses what that means for oncology.
⬇️ Check it out now ⬇️
https://t.co/xzgolZDIcI
#bcsm #crcsm #Oncology
Blood clots take 100,000 lives each year in the U.S. But one unexpected hospital friendship changed the outcome and saved a man’s life. Watch more via @CBSNews. #BloodClotAwareness https://t.co/aqM9LbZTsv
In honor of Doctors' Day, we hosted a special luncheon to recognize all of our physicians for going above and beyond to care for our patients. Thank you to all of our doctors for their dedication, compassion, and service!
Myth: You're too young for colorectal cancer. Reality: It's the #1 cause of cancer death for those under 50.
Dr. @StevenDWexner reveals the symptoms you shouldn’t ignore.
77% of people don’t know the correct age to get your first colonoscopy (it’s 45). Screening is your best defense against colorectal cancer, which is highly treatable when caught early. Learn more about colorectal cancer and discover your risk. https://t.co/3gvDhIK8hC
Cancer treatments are effective, but prevention is even better. New @MedStarResearch explores how genetic testing can help protect your family’s future by bridging communication gaps. Learn more from Dr. Kristen Whitaker. https://t.co/3kTfVzWXUl
New @MedStarResearch could change how millions of people get care for sepsis. Discover how a new, specific AI-based blood test could reduce unnecessary antibiotic use by 60% to 70% from @DrMFischer and Dr. Suzanne Simkovich. https://t.co/GkJtLiK7oc
For people with severe, recurrent vasovagal syncope that won't respond to meds, cardioneural ablation could be a game-changer. Electrophysiologist Dr. Tsimploulis explains how this minimally invasive procedure recalibrates your heart’s "autopilot". https://t.co/OOgDLAhu4S
Learn about symptoms and risk factors, the benefits of early diagnosis, and advanced treatment options from Dr. Jonathan Lischalk, @KeithKow, and @RamnaraignMD. https://t.co/xrzYa3OCFU
For patients with locally advanced head and neck squamous-cell carcinoma, phase 2 studies indicated that adding perioperative pembrolizumab to standard care improved outcomes. Findings from KEYNOTE-689 phase 3 trial are summarized in a short video. https://t.co/I4ke5fTD9C
Watch this @nbcwashington story about a heartwarming meeting between Keri Ayres, a kidney donor, who met the stranger who received her kidney, Walter Lanier. If you have questions about donating a kidney, please call: 202-444-3714. https://t.co/cODmoLL90S
Watch Dr. Matthew Witek, director of Proton Therapy at MedStar Georgetown, explain how proton therapy treats cancer. To learn more or to make an appointment call (202) 444-4255, or visit https://t.co/537UsZHxPV.